Estamos no ar no ! Saiba mais
ícone de BBC

Virtus Biotech Clinical Trials ETF

Nome Posição Valor negociado Ações
Variação
Variação na
participação
Goldman Sachs
1
Goldman Sachs
New York
US$ 3,62 mi -US$ 3,44 mi -100.000 -50%
Jane Street
2
Jane Street
New York
US$ 2,07 mi +US$ 1,37 mi +39.905 +232%
Virtu KCG Holdings
3
Virtu KCG Holdings
New York
US$ 1,13 mi +US$ 1,08 mi +31.275 Nova
LPL Financial
4
LPL Financial
California
US$ 897 mil +US$ 192 mil +5.571 +29%
Credit Suisse
5
Credit Suisse
Switzerland
US$ 511 mil -US$ 5,33 mil -155 -1%
Baker Avenue Asset Management
6
Baker Avenue Asset Management
California
US$ 254 mil -US$ 38,2 mil -1.110 -14%
Ladenburg Thalmann Financial Services
7
Ladenburg Thalmann Financial Services
Florida
US$ 80 mil +US$ 75,6 mil +2.200 Nova
UBS Group
8
UBS Group
Switzerland
US$ 31 mil +US$ 21,5 mil +624 +267%
American International Group
9
American International Group
New York
US$ 9,06 mil +US$ 8,6 mil +250 Nova
Morgan Stanley
10
Morgan Stanley
New York
US$ 3 mil -US$ 3,44 mil -100 -59%
Tower Research Capital (TRC)
11
Tower Research Capital (TRC)
New York
– -US$ 53,8 mil -1.566 -100%
MassMutual Private Wealth & Trust
12
MassMutual Private Wealth & Trust
Connecticut
– -US$ 8,14 mil -248 Encerrada
Creative Planning
13
Creative Planning
Kansas
– -US$ 7 mil -200 Encerrada